Abstract
Patient/caregiver out-of pocket costs associated with hematopoietic cell transplantation (HCT) are not well known. We conducted a pilot study to evaluate patient/caregiver out-of-pocket costs in the first 3 months after allogeneic HCT. Thirty patients were enrolled at three sites. Before HCT, participants completed a baseline survey regarding household income and insurance coverage. Subsequently, they maintained a paper-based diary to track daily out-of-pocket expenses for the first 3 months after HCT. Telephone interviews were conducted to follow-up on the missing/incomplete diaries and on study completion. Twenty-five patients/caregivers completed the baseline survey. Among these, the median pre-tax household income was $66 500 (range, $30–$375 000) and 48% had to temporarily relocate close to the transplant center. Insurance coverage was managed care plan (56%), Medicaid (20%), Medicare (17%) and other (8%). Twenty-two patients/caregivers completed ⩾4 diaries; the median out-of-pocket expenses were $2440 (range, $199–$13 769). Patients/caregivers who required temporary lodging had higher out-of-pocket expenses compared with those who did not (median, $5247 vs $716). Patients/caregivers can incur substantial out-of-pocket costs over the first 3 months, especially if they need to temporarily relocate close to the transplant center. Our study lays the foundation for future research on the early and long-term financial impact of allogeneic HCT on patients/caregivers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Preussler JM, Denzen EM, Majhail NS . Costs and cost-effectiveness of hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012; 18: 1620–1628.
Lee SJ, Klar N, Weeks JC, Antin JH . Predicting costs of stem-cell transplantation. J Clin Oncol 2000; 18: 64–71.
Majhail NS, Mothukuri JM, Brunstein CG, Weisdorf DJ . Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications. Biol Blood Marrow Transplant 2009; 15: 564–573.
Majhail NS, Mothukuri JM, Macmillan ML, Verneris MR, Orchard PJ, Wagner JE et al. Costs of pediatric allogeneic hematopoietic-cell transplantation. Pediatr Blood Cancer 2010; 54: 138–143.
Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP et al. Costs of allogeneic hematopoietic cell transplantation with high-dose regimens. Biol Blood Marrow Transplant 2008; 14: 197–207.
Saito AM, Zahrieh D, Cutler C, Ho VT, Antin JH, Soiffer RJ et al. Lower costs associated with hematopoietic cell transplantation using reduced intensity vs high-dose regimens for hematological malignancy. Bone Marrow Transplant 2007; 40: 209–217.
Stranges E, Russo CA, Friedman B . Procedures with the most rapidly increasing hospital costs, 2004–2007. HCUP Statistical Brief #82. Agency for Healthcare Research and Quality: Rockville, MDhttp://www.hcup-us.ahrq.gov/reports/statbriefs/sb82.pdf2009.
Khera N, Zeliadt SB, Lee SJ . Economics of hematopoietic cell transplantation. Blood 2012; 120: 1545–1551.
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM, Blum D et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol 2009; 27: 3868–3874.
Wagner L, Lacey MD . The hidden costs of cancer care: an overview with implications and referral resources for oncology nurses. Clin J Oncol Nurs 2004; 8: 279–287.
Kim P . Cost of cancer care: the patient perspective. J Clin Oncol 2007; 25: 228–232.
Meehan KR, Fitzmaurice T, Root L, Kimtis E, Patchett L, Hill J . The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients. J Support Oncol 2006; 4: 187–190.
Frey P, Stinson T, Siston A, Knight SJ, Ferdman E, Traynor A et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant 2002; 30: 741–748.
Rizzo JD, Vogelsang GB, Krumm S, Frink B, Mock V, Bass EB . Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? J Clin Oncol 1999; 17: 2811–2818.
Cohn RJ, Goodenough B, Foreman T, Suneson J . Hidden financial costs in treatment for childhood cancer: an Australian study of lifestyle implications for families absorbing out-of-pocket expenses. J Pediatr Hematol Oncol 2003; 25: 854–863.
Goossens ME, Rutten-van Molken MP, Vlaeyen JW, van der Linden SM . The cost diary: a method to measure direct and indirect costs in cost-effectiveness research. J Clin Epidemiol 2000; 53: 688–695.
Eiser C, Upton P . Costs of caring for a child with cancer: a questionnaire survey. Child Care Health Dev 2007; 33: 455–459.
Longo CJ, Deber R, Fitch M, Williams AP, D'Souza D . An examination of cancer patients' monthly 'out-of-pocket' costs in Ontario, Canada. Eur J Cancer Care 2007; 16: 500–507.
Longo CJ, Fitch M, Deber RB, Williams AP . Financial and family burden associated with cancer treatment in Ontario, Canada. Support Care Cancer 2006; 14: 1077–1085.
Pope C, Ziebland S, Mays N . Qualitative research in health care. Analysing qualitative data. BMJ 2000; 320: 114–116.
Burnard P . A method of analysing interview transcripts in qualitative research. Nurse Educ Today 1991; 11: 461–466.
Krueger RA, Casey MA . Focus groups: A practical guide for applied research. 3rd edn. Sage Publications: Thousand Oaks, CA, 2009.
Majhail NS, Omondi NA, Denzen E, Murphy EA, Rizzo JD . Access to hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant 2010; 16: 1070–1075.
Acknowledgements
We acknowledge the contribution of Tammy Payton, National Marrow Donor Program Patient Services department, in assisting with the analysis of qualitative data. We thank the study coordinators at the Medical College of Wisconsin (Leigh Ann Laczkowski), the Roswell Park Cancer Institute (Dana Cipolla, Lise Hernandez) and the University of Minnesota (Jenna Johnson, Becky Draxler) for their help in enrolling patients on the study. The National Marrow Donor Program provided funding for gift cards for study participants. The Center for International Blood and Marrow Transplant Research is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 5U01HL069294 from NHLBI and NCI; a contract HHSH234200637015C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-06-1-0704 and N00014-08-1-0058 from the Office of Naval Research; and grants from AABB; Allos, Inc.; Amgen, Inc.; Anonymous donation to the Medical College of Wisconsin; Astellas Pharma US, Inc.; Be the Match Foundation; Biogen IDEC; BioMarin Pharmaceutical, Inc.; Biovitrum AB; BloodCenter of Wisconsin; Blue Cross and Blue Shield Association; Bone Marrow Foundation; Buchanan Family Foundation; CaridianBCT; Celgene Corporation; CellGenix, GmbH; Children’s Leukemia Research Association; ClinImmune Labs; CTI Clinical Trial and Consulting Services; Eisai, Inc.; Genentech, Inc.; Genzyme Corporation; Histogenetics, Inc.; HKS Medical Information Systems; Hospira, Inc.; Kirin Brewery Co., Ltd.; The Leukemia & Lymphoma Society; Merck & Company; The Medical College of Wisconsin; Millennium Pharmaceuticals, Inc.; Miller Pharmacal Group; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Nature Publishing Group; Novartis Oncology; Oncology Nursing Society; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Pall Life Sciences; Pfizer Inc; Schering Corporation; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, Inc.; StemSoft Software, Inc.; Sysmex America, Inc.; THERAKOS, Inc.; Vidacare Corporation; ViraCor Laboratories; ViroPharma, Inc.; and Wellpoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institutes of Health, the Department of the Navy, the Department of Defense, or any other agency of the US Government.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on Bone Marrow Transplantation website
Supplementary information
Rights and permissions
About this article
Cite this article
Majhail, N., Rizzo, J., Hahn, T. et al. Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 48, 865–871 (2013). https://doi.org/10.1038/bmt.2012.248
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2012.248
Keywords
This article is cited by
-
Cost of HSCT in a Tertiary Care Public Sector Hospital in India
Indian Journal of Hematology and Blood Transfusion (2022)
-
Prevalence and correlates of psychological distress, unmet supportive care needs, and fear of cancer recurrence among haematological cancer patients during the COVID-19 pandemic
Supportive Care in Cancer (2021)
-
Health-Related and Economic Burden Among Family Caregivers of Patients with Acute Myeloid Leukemia or Hematological Malignancies
Advances in Therapy (2021)
-
Relationship between paid leave, financial burden, and patient-reported outcomes among employed patients who have undergone bone marrow transplantation
Quality of Life Research (2019)
-
Costs of hematopoietic stem cell transplantation in a developing country
International Journal of Hematology (2017)